Product Reports Resources Pricing Login Book a demo

Pathway Genomics

Biotech & Life Sciences · San Diego, United States · Founded 2008

Global clinical lab offering genetic tests for cancer risk, drug responses, and many other conditions

Valuation $100–500M
Headcount <100
Total funding $10–50M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Pathway Genomics and the history behind them.

Company overview

Pathway Genomics company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2008
Headquarters
San Diego, United States
Employees
34
Open positions
None listed
Dealroom signal
17.8
LinkedIn ↗X ↗
client focusb2btechnologyArtificial IntelligencetechnologyDeep TechtechnologyMachine Learningsub industryBioTechnologybusiness modelManufacturingsectorTestingindustryHealthsectorRisk ManagementsectorBiotechnologysectorOncologysectorDNAsectorGenetics and genomicssectorCore AI

Valuation & funding

Pathway Genomics funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
OtherOther financing Nov 2021 $0 — Undisclosed —
SERIES E✓Equity / VC Jan 2016 $40M $160M IBM —
SERIES A✓Equity / VC Jul 2009 $3M $12M Undisclosed —
Showing 3 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 34
2025 34
2024 34
2023 34
2022 34
2021 34
2020 39
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Pathway Genomics website traffic

Latest recorded traffic for Pathway Genomics is 15K monthly website visits, up 500% over the last three months. Pathway Genomics's team grew 0% over the past year.

Latest monthly visits15K 3-month web change+500% 1-year team growth0%
Monthly website visits64 observations · Jan 2017–Oct 2022
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Pathway Genomics compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
InSilico MedicineDevelops an AI platform for drug development to treat cancer and age-related diseases Cambridge, United States Operational 294 $532M $3B
Emedgene technologiesEmedgene uses AI to automatically interpret genetic tests, so that health organizations can scale personalized care to wider populations Palo Alto, United States Acquired
Fabric GenomicsGlobal healthcare platform for genomic data analysis - Formerly Omicia San Francisco, United States Acquired
Pear TherapeuticsPear discovers, develops, and commercializes Prescription Digital Therapeutics to treat diseases with high unmet need Boston, United States Operational
Cancer Genetics (Vyant Bio)Cancer Genetics is laboratory that develops and commercializes proprietary genomic tests and services to empower cancer treatment Rutherford, United States Operational
Guardant HealthImproving patient health through technology breakthroughs in oncology. Palo Alto, United States Operational
23andMeHelping people access, understand, and benefit from the human genome Sunnyvale, United States Acquired
JunglaWe increasingly look to our genomes for answers Jungla is committed to ensuring we find them South San Francisco, United States Operational
Showing 8 of the closest matchesCompare every metric →

Talent graph

Pathway Genomics's talent

Book a demo to see the people
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

4 investors on Pathway Genomics's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series B+ 1 investor entered at this stage
IBM
Other known 3 additional known investors
Agoranov
Creative Destruction Lab
Startport

Global footprint

Where Pathway Genomics has talent and traffic

Workforce by country
🇺🇸 United States · San Diego HQ
Book a demo for the full country breakdown

In the news

Latest news about Pathway Genomics

Recent press, funding announcements, and product moves mentioning Pathway Genomics — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Pathway Genomics

An AI-synthesized read of the highest-engagement posts about Pathway Genomics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Pathway Genomics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.